These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3427169)

  • 1. A two-stage procedure for bioequivalence studies.
    Racine-Poon A; Grieve AP; Flühler H; Smith AF
    Biometrics; 1987 Dec; 43(4):847-56. PubMed ID: 3427169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-stage design for choosing among several experimental treatments and a control in clinical trials.
    Thall PF; Simon R; Ellenberg SS
    Biometrics; 1989 Jun; 45(2):537-47. PubMed ID: 2765637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential design approaches for bioequivalence studies with crossover designs.
    Potvin D; DiLiberti CE; Hauck WW; Parr AF; Schuirmann DJ; Smith RA
    Pharm Stat; 2008; 7(4):245-62. PubMed ID: 17710740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian approach to bioequivalence for the 2 x 2 changeover design.
    Selwyn MR; Dempster AP; Hall NR
    Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for the evaluation of individual bioequivalence.
    Endrenyi L
    Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations.
    Panchagnula R; Parmar J; Kaur JK; Singh I; Bhade SR
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):161-7. PubMed ID: 16810342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact significance testing to establish treatment equivalence with ordered categorical data.
    Mehta CR; Patel NR; Tsiatis AA
    Biometrics; 1984 Sep; 40(3):819-25. PubMed ID: 6518249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-stage clinical trial stopping rules.
    Elashoff JD; Reedy TJ
    Biometrics; 1984 Sep; 40(3):791-5. PubMed ID: 6518247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On Bayesian methods for bioequivalence.
    Selwyn MR; Hall NR
    Biometrics; 1984 Dec; 40(4):1103-8. PubMed ID: 6398710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetry of the mean-variability tradeoff raises questions about the model in investigations of individual bioequivalence.
    Endrenyi L; Hao Y
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):450-7. PubMed ID: 9726700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-sample multiple testing procedure for phase II clinical trials.
    Fleming TR
    Biometrics; 1982 Mar; 38(1):143-51. PubMed ID: 7082756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further results on a multiple-testing procedure for clinical trials.
    Seigel D; Milton RC
    Biometrics; 1983 Dec; 39(4):921-8. PubMed ID: 6671127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.